Clinical Trial Update: Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease [Phase 3]

View source ↗

Summary

Phase 3 multicenter extension study of velaglucerase alfa in Japanese patients with Gaucher disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Velaglucerase alfa (velaglucerase alfa)

Snippet

Sponsor: Shire | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-12-14